These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16161415)

  • 1. [The use of DNA analysis for diagnostics of hereditary premature ovarian failure].
    Livshyts' HB; Kravchenko SA; Hryshchenko NV; Sudoma IA
    Tsitol Genet; 2005; 39(2):59-63. PubMed ID: 16161415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
    Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
    Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile X syndrome.
    Terracciano A; Chiurazzi P; Neri G
    Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):32-7. PubMed ID: 16010677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From gene to disease; fragile X-syndrome: hereditary mental retardation due to a developmental gene].
    de Vries LB; Oostra BA
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):474-6. PubMed ID: 11268909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.
    Bodega B; Bione S; Dalprà L; Toniolo D; Ornaghi F; Vegetti W; Ginelli E; Marozzi A
    Hum Reprod; 2006 Apr; 21(4):952-7. PubMed ID: 16361284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature ovarian failure: a phenotypic expression of fragile X premutation.
    Holoch K; Stein Q; Flanagan J; Hansen K
    S D Med; 2008 Jan; 61(1):13, 15. PubMed ID: 18323308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for Fragile X syndrome mutations during early pregnancy--results and mothers' opinions about the gene test].
    Ryynänen M; Heinonen S; Makkonen M; Mannermaa A; Kirkinen P
    Duodecim; 1998; 22(114):2323-9. PubMed ID: 11757093
    [No Abstract]   [Full Text] [Related]  

  • 9. A fragile balance: FMR1 expression levels.
    Oostra BA; Willemsen R
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R249-57. PubMed ID: 12952862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern.
    Rodriguez-Revenga L; Madrigal I; Badenas C; Xunclà M; Jiménez L; Milà M
    Menopause; 2009; 16(5):944-9. PubMed ID: 19373114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of fragile X syndrome].
    Glover G; Bernabé MJ; Carbonell P
    Rev Neurol; 2001 Oct; 33 Suppl 1():S6-9. PubMed ID: 12447811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
    De Caro JJ; Dominguez C; Sherman SL
    Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of FMR1 repeat size with ovarian dysfunction.
    Sullivan AK; Marcus M; Epstein MP; Allen EG; Anido AE; Paquin JJ; Yadav-Shah M; Sherman SL
    Hum Reprod; 2005 Feb; 20(2):402-12. PubMed ID: 15608041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The genetic basis of premature ovarian failure].
    Monnier-Barbarino P; Forges T
    J Gynecol Obstet Biol Reprod (Paris); 2002 Jun; 31(4):333-42. PubMed ID: 12058137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal function of ovaries in women carriers of premutation in the FMR1 gene].
    Lisik MZ
    Wiad Lek; 2007; 60(5-6):265-9. PubMed ID: 17966892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case report.
    Miano MG; Laperuta C; Chiurazzi P; D'Urso M; Ursini MV
    BMC Med Genet; 2007 Apr; 8():18. PubMed ID: 17428316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.